Results consistent with previous trials, reinforcing benefit of Daiichi Sankyo and AstraZeneca’s ENHERTU in previously treated patients
Donor privilege cards given to the families of all the donors from across Karnataka as a token of appreciation
Company creates Younger T Cells for fighting cancer using its NR2F6 technology
Based on DESTINY-Breast04 results which showed Daiichi Sankyo and AstraZeneca’s ENHERTU reduced risk of disease progression or death by 50% and increased overall survival by more than six months versus chemotherapy
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
The safety profile of KEYTRUDA plus LENVIMA was consistent with previously reported data on the combination.
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
Apollo Hospitals Chennai is the first healthcare institution in South India to use this protected TAVI / TAVR technology.
Subscribe To Our Newsletter & Stay Updated
